Search Results - "Tanner, Edward J"

Refine Results
  1. 1

    FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway by Zhang, Yaqi, Wang, Yinu, Zhao, Guangyuan, Tanner, Edward J, Adli, Mazhar, Matei, Daniela

    Published in The Journal of clinical investigation (16-05-2022)
    “…Understanding the regulatory programs enabling cancer stem cells (CSCs) to self-renew and drive tumorigenicity could identify new treatments. Through…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer by Chen, Siqi, Xie, Ping, Cowan, Matthew, Huang, Hao, Cardenas, Horacio, Keathley, Russell, Tanner, Edward J, Fleming, Gini F, Moroney, John W, Pant, Alok, Akasha, Azza M, Davuluri, Ramana V, Kocherginsky, Masha, Zhang, Bin, Matei, Daniela

    Published in The Journal of clinical investigation (15-07-2022)
    “…BackgroundImmune checkpoint inhibitors (ICIs) have modest activity in ovarian cancer (OC). To augment their activity, we used priming with the hypomethylating…”
    Get full text
    Journal Article
  4. 4

    Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis by Bodurtha Smith, Anna Jo, MD, MPH, MSc, Fader, Amanda Nickles, MD, Tanner, Edward J., MD

    “…Background In the staging of endometrial cancer, controversy remains regarding the role of sentinel lymph node mapping compared with other nodal assessment…”
    Get full text
    Journal Article
  5. 5

    Lymphopenia and its association with survival in patients with locally advanced cervical cancer by Wu, Emily S, Oduyebo, Titilope, Cobb, Lauren P, Cholakian, Diana, Kong, Xiangrong, Fader, Amanda N, Levinson, Kimberly L, Tanner, Edward J, Stone, Rebecca L, Piotrowski, Anna, Grossman, Stuart, Long Roche, Kara

    Published in Gynecologic oncology (01-01-2016)
    “…Abstract Objective To evaluate the association between lymphopenia and survival in women with cervical cancer treated with primary chemoradiation. Methods A…”
    Get full text
    Journal Article
  6. 6

    Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations by Polan, Rosa M., Ali-Fehmi, Rouba, Grace, Anne K., Mattei, Larissa H., Tanner, Edward J., Morris, Robert T.

    Published in Gynecologic oncology (01-10-2024)
    “…To describe extension of ovarian tissue beyond visible and National Comprehensive Cancer Network recommended margins among patients with BRCA mutations…”
    Get full text
    Journal Article
  7. 7

    A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer by Tanner, Edward J., Filippova, Olga T., Gardner, Ginger J., Long Roche, Kara C., Sonoda, Yukio, Zivanovic, Oliver, Fischer, Mary, Chi, Dennis S.

    Published in Gynecologic oncology (01-12-2018)
    “…Our objective was to determine the safety and efficacy of acute normovolemic hemodilution (ANH) to reduce the requirement for allogenic red blood cell (RBC)…”
    Get full text
    Journal Article
  8. 8

    Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer by Beavis, Anna L, Salazar-Marioni, Sergio, Sinno, Abdulrahman K, Stone, Rebecca L, Fader, Amanda N, Santillan-Gomez, Antonio, Tanner, Edward J

    Published in Gynecologic oncology (01-11-2016)
    “…Abstract Objective Our study objective was to determine feasibility and mapping rates using indocyanine green (ICG) for sentinel lymph node (SLN) mapping in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity by Fader, Amanda N., Weise, R. Matsuno, Sinno, Abdulrahman K., Tanner, Edward J., Borah, Bijan J., Moriarty, James P., Bristow, Robert E., Makary, Martin A., Pronovost, Peter J., Hutfless, Susan, Dowdy, Sean C.

    Published in Obstetrics and gynecology (New York. 1953) (01-01-2016)
    “…To describe case mix-adjusted hospital level utilization of minimally invasive surgery for hysterectomy in the treatment of early-stage endometrial cancer. In…”
    Get full text
    Journal Article
  11. 11

    Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma by Yen, Ting-Tai, Miyamoto, Tsutomu, Asaka, Shiho, Chui, M. Herman, Wang, Yeh, Lin, Shiou-Fu, Stone, Rebecca L., Fader, Amanda N., Asaka, Ryoichi, Kashima, Hiroyasu, Shiozawa, Tanri, Wang, Tian-Li, Shih, Ie-Ming, Tanner, Edward J.

    Published in Gynecologic oncology (01-09-2018)
    “…Inactivating somatic mutations of ARID1A, a chromatin remodeling gene, are common in endometrioid endometrial carcinoma (EEC) but rare in complex atypical…”
    Get full text
    Journal Article
  12. 12

    Feasibility of Robotic-Assisted Laparoendoscopic Single-Site Surgery in the Gynecologic Oncology Setting by Moukarzel, Lea A., MD, Fader, Amanda N., MD, Tanner, Edward J., MD

    Published in Journal of minimally invasive gynecology (01-02-2017)
    “…Abstract Study Objective To assess the feasibility of incorporating robotic laparoendoscopic single-site (R-LESS) surgery into gynecologic oncology care…”
    Get full text
    Journal Article
  13. 13

    Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis by Moukarzel, Lea A., M.D, Sinno, Abdulrahman K., M.D, Fader, Amanda N., M.D, Tanner, Edward J., M.D

    Published in Journal of minimally invasive gynecology (01-09-2017)
    “…Abstract Study Objective To compare operative times, surgical outcomes, and costs of robotic laparo-endoscopic single-site (R-LESS) versus multiport robotic…”
    Get full text
    Journal Article
  14. 14

    The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study by Fader, Amanda Nickles, Java, James, Krivak, Thomas C, Bristow, Robert E, Tergas, Ana I, Bookman, Michael A, Armstrong, Deborah K, Tanner, Edward J, Gershenson, David M

    Published in Gynecologic oncology (01-03-2014)
    “…Abstract Objectives The study objective was to determine the prognostic significance of serum CA-125 levels in patients with grade 1 serous ovarian carcinoma…”
    Get full text
    Journal Article
  15. 15

    Disparities in Surgical Care Among Women With Endometrial Cancer by Mannschreck, Diana, Matsuno, Rayna K., Moriarty, James P., Borah, Bijan J., Dowdy, Sean C., Tanner, Edward J., Makary, Martin A., Stone, Rebecca L., Levinson, Kimberly L., Temkin, Sarah M., Fader, Amanda N.

    Published in Obstetrics and gynecology (New York. 1953) (01-09-2016)
    “…OBJECTIVE:To analyze contemporary U.S. use of minimally invasive surgery for the treatment of endometrial cancer and associated inpatient complications and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer by Cholakian, Diana, Hacker, Kari, Fader, Amanda N, Gehrig, Paola A, Tanner, Edward J

    Published in Gynecologic oncology (01-02-2016)
    “…Abstract Objective The objective of this analysis was to evaluate weight changes associated with oral progestin therapies versus the levonorgestrel-containing…”
    Get full text
    Journal Article
  18. 18

    A microRNA survival signature (MiSS) for advanced ovarian cancer by Shih, Karin K, Qin, Li-Xuan, Tanner, Edward J, Zhou, Qin, Bisogna, Maria, Dao, Fanny, Olvera, Narciso, Viale, Agnes, Barakat, Richard R, Levine, Douglas A

    Published in Gynecologic oncology (01-06-2011)
    “…Abstract Objectives MicroRNAs (miRNAs) are a class of small non-coding RNAs that negatively regulate gene expression primarily through post-transcriptional…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Optimizing a Behavioral Sleep Intervention for Gynecologic Cancer Survivors: Study Design and Protocol by Fox, Rina S, Gaumond, Julia S, Zee, Phyllis C, Kaiser, Karen, Tanner, Edward J, Ancoli-Israel, Sonia, Siddique, Juned, Penedo, Frank J, Wu, Lisa M, Reid, Kathryn J, Parthasarathy, Sairam, Badger, Terry A, Rini, Christine, Ong, Jason C

    Published in Frontiers in neuroscience (04-03-2022)
    “…Sleep difficulties, particularly symptoms of insomnia and circadian disruption, are among the primary complaints of gynecologic cancer survivors before,…”
    Get full text
    Journal Article